跳至主要内容
临床试验/EUCTR2004-005043-97-GB
EUCTR2004-005043-97-GB进行中(未招募)不适用

A Pilot study investigating the use of Intravitreal Triamcinolone prior to macular laser for Clinically Significant Diabetic Macular Oedema - CSMO and triamcinolone

St Mary's NHS Trust0 个研究点目标入组 50 人开始时间: 2005年4月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Diabetes Mellitus
  • 2) Clinically significant macular oedema as defined by the ETDRS studies
  • 3) Visual Acuity worse than 6/12 (0.3 LogMAR)
  • 4) OCT thickness greater than 300um
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Retinal pathology other than that due to Diabetes
  • 2) Glaucoma, ocular hypertension or known steroid responder
  • 3) Previous laser treatment
  • 4) Only eyes
  • 5) Visual acuity better than 6/12
  • 6) Proliferative diabetic retinopathy
  • 7) Unable to attend for follow up
  • 8) Unfit for a local anaesthetic (LA) procedure
  • 9) Unable to consent fully

研究者

发起方
St Mary's NHS Trust

相似试验